China Approved its First Cell Therapy
Shi Yingzi · 07/19/2021
On June 22, NMPA green-lighted Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B cell lymphoma.
READ MORE
NMPA Re-elected as ICH Management Committee Member, ...
Minhua Chu · 07/19/2021
"The NMPA stands in the international arena with clear goals and intentions and will actively participate in the ICH’s international affairs in the future."
READ MORE
New Regulations for Post-Market Drug Changes Remain...
editor · 07/19/2021
Recently, the National Medical Products Administration issued regulations for post-approval changes in medicinal products (for pilot implementation).
READ MORE
Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement